This technique is especially suitable for detection of hotspot alterations, such as MYD88 L265P and CD79B Y196, and already allowed for non-invasive real-time monitoring of disease progression in systemic DLBCL patients [24,25,26]. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.